정부/공공기관
임상시험센터
CRO
분석CRO/센트럴랩
유관기관/협회
정보서비스
해외 유관 기관
* CRO 게재 기준: CRO자율등록 기관
ClinicalTrials.gov에 등록된 정보를 기준으로 코로나-19(COVID-19) 관련 글로벌 임상시험 현황을 제공합니다.
전체 2550건이 검색되었습니다.
| No. | Status | Study Title | Conditions | Interventions | Phase | Sponsor/Collaborators | Funder Type | Number Enrolled | Sex | Age | Locations |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 303 | Terminated | Switch of Renin-Angiotensin System Inhibitors in Patients With Covid-19 | Angiotensin II Receptor Antagonist Adverse Reaction | Drug: Renin-angiotensin system inhibitors | Phase 3 | University of Sao Paulo | OTHER | 18 | All | 18 Years ~ 80 Years | Instituto do Coracao - Incor HCFMUSP, Sao Paulo, SP, Brazil |
| 302 | Recruiting | Synthetic CBD as a Therapy for COVID-19 | CBD | Drug: CBD Drug: Placebo |
Phase 1 | Sheba Medical Center | OTHER_GOV | 50 | All | 18 Years | Sheba Medical Center, Tel Hashomer, Ramat Gan, Tel Aviv, Israel |
| 301 | Recruiting | Systemic Corticosteroids in Treatment of Post-COVID-19 Interstitial Lung Disease | Interstitial Lung Disease | Drug: Methylprednisolone Tablet | Phase 4 | Turkish Thoracic Society | OTHER | 642 | All | 18 Years | Ufuk University Medicine Faculty, Ankara, Turkey |
| 300 | Suspended | Systems Analyses of the Immune Response to the Seasonal Influenza Vaccine | COVID-19 | Biological: Flucelvax Biological: Fluvirin Biological: Fluzone High Dose |
Phase 2 | National Institute of Allergy and Infectious Diseases (NIAID) | NIH | 90 | All | 18 Years | National Institutes of Health Clinical Center, Bethesda, Maryland, United States |
| 299 | Active, not recruiting | Tableted COVID-19 Therapeutic Vaccine | Covid19 | Biological: V-SARS | Phase 2 | Immunitor LLC, Immunitor Inc. | INDUSTRY | 20 | All | 18 Years ~ 65 Years | Immunitor Inc, Vancouver, BC - British Columbia, Canada Aldar Bourinbayar, Ulaanbaatar, BZD, 3-khoroo, Mongolia |
| 298 | Not yet recruiting | TAF/FTC for Pre-exposure Prophylaxis of COVID-19 in Healthcare Workers (CoviPrep Study) | SARS-CoV 2 | Drug: Emtricitabine/Tenofovir Alafenamide 200 MG-25 MG Oral Tablet Drug: Placebo |
Phase 3 | Hospital Italiano de Buenos Aires, Sociedad Argentina de Infectologia (SADI) (Argentine Society of Infectious Diseases) | OTHER | 1378 | All | 18 Years | Sociedad Argentina de Infectologia, A. J. Carranza 974, Ciudad Autonoma de Buenos Aires, Capital Federal, Argentina |
| 297 | Active, not recruiting | Tafenoquine in Patients With Mild to Moderate COVID-19 | COVID 19 Disease | Drug: Tafenoquine Oral Tablet Drug: Placebo |
Phase 2 | 60 Degrees Pharmaceuticals LLC | INDUSTRY | 275 | All | 18 Years | Deluxe Health Center LLC, Miami, Florida, United States Hope Clinical Trials, Miami, Florida, United States F&T Medical Research, Inc., Miami, Florida, United States Kendall South Medical Center, Inc., Miami, Florida, United States Skyline Medical Center, Elkhorn, Nebraska, United States Burke Primary Care, Morgantown, North Carolina, United States AFC Urgent Care, Easley, South Carolina, United States Centex Studies, Brownsville, Texas, United States Care United, Forney, Texas, United States Clinical Trial Network, Houston, Texas, United States |